A Long-term Observational Study Cohort in Patients With Advanced Prostate Cancer
NCT01383863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2019-01-14
Summary
The purpose of the protocol is to assess the rate of castration resistance, disease progression and overall survival over a 3-year period post-androgen deprivation therapy (ADT) induction in a study cohort of patients with advanced disease.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Ipsen Medical Director · Ipsen
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-10-31
- Primary Completion
- 2014-05-31
- Completion
- 2014-05-31
Countries
- Denmark
- France
- Latvia
- Lithuania
- Netherlands
- Romania
- United Kingdom
Study Locations
More Related Trials
-
To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients
NCT03017313 ·Status: COMPLETED
-
Androgen-Deprivation Therapy and Cardiovascular Risk: A Nationwide Population-based Cohort Study
NCT02895230 ·Status: COMPLETED
-
Study of Lanreotide in Non Metastatic Castration-resistant Prostate Cancer Patients
NCT01313273 ·Status: TERMINATED ·Phase: PHASE3
-
Effects of Triptorelin When Given Every 6-months Under the Skin to Adult Males With Cancer in the Prostate
NCT05458856 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Aggressive Prostate Cancer in Real Life: Initiation, Schedule and Management of Triptorelin Treatment.
NCT04593420 ·Status: COMPLETED
-
A Study of Immediate 9 Months Adjuvant Hormone Therapy With Triptorelin 11.25 mg Versus Active Surveillance After Radical Prostatectomy in High Risk Prostate Cancer Patients.
NCT01753297 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Apalutamide, Radiotherapy, and LHRH Agonist in Prostate Cancer Patients After Prostatectomy
NCT04181203 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases
NCT04523207 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer
NCT01374087 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of Shorter Course Hormone Therapy and Radiation for High-risk Prostate Cancer
NCT05100472 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy
NCT03516110 ·Status: COMPLETED
-
Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer
NCT01715129 ·Status: COMPLETED ·Phase: PHASE3
-
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer
NCT01819285 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical Prostatectomy
NCT05169112 ·Status: RECRUITING ·Phase: PHASE3
-
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
NCT01431391 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer
NCT02175212 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life for Subjects Receiving Androgen Deprivation Therapy and Have a Doubling in PSA of Either Less Than or Greater Than 1 Year
NCT00703768 ·Status: UNKNOWN
-
Evaluation of Clinical Outcomes of Chemotherapy or Androgen-receptor Targeting Agent (Alone or Combined) or Radiotherapy on Primary Tumor in Addition to Androgen Deprivation Therapy in HOrmone-Sensitive Metastatic Prostate Cancer Patients
NCT06473259 ·Status: RECRUITING
-
Prostate Adenocarcinoma TransCutaneous Hormones
NCT00303784 ·Status: UNKNOWN ·Phase: PHASE3
-
Experiment to Assess Preferences for Novel Hormonal Therapy and Androgen-deprivation Therapy in Prostate Cancer Patients
NCT06500741 ·Status: COMPLETED
-
Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly
NCT00161252 ·Status: WITHDRAWN
-
Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer
NCT00667069 ·Status: COMPLETED ·Phase: PHASE3
-
Prostatic Cancer Versus Androgen Deficiency
NCT02235142 ·Status: COMPLETED ·Phase: NA
-
Treatment Patterns Among Patients With Prostate Cancer Prior to Diagnosis of a Castration-resistant State
NCT01560858 ·Status: COMPLETED
-
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
NCT03511196 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1